United Capital Financial Advisors’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-59,941
Closed -$2.59M 1122
2022
Q2
$2.59M Sell
59,941
-5
-0% -$229 0.01% 446
2022
Q1
$3.24M Buy
59,946
+4,147
+7% +$212K 0.02% 436
2021
Q4
$3.34M Sell
55,799
-175
-0.3% -$10.9K 0.02% 446
2021
Q3
$3.67M Sell
55,974
-16,358
-23% -$1.06M 0.02% 418
2021
Q2
$4.57M Buy
72,332
+3,452
+5% +$198K 0.02% 386
2021
Q1
$3.36M Sell
68,880
-10,000
-13% -$480K 0.02% 416
2020
Q4
$3.25M Hold
78,880
0.02% 416
2020
Q3
$3.65M Buy
78,880
+8,306
+12% +$385K 0.02% 389
2020
Q2
$3.09M Hold
70,574
0.02% 434
2020
Q1
$2.8M Buy
+70,574
New +$3.16M 0.02% 434

Other funds holding KIDS

United Capital Financial Advisors's KIDS Position: Q3 2022 in Review

United Capital Financial Advisors sold out of OrthoPediatrics (KIDS) in Q3 2022, closing a stake of 59,941 shares — an estimated $2.59M sold.

United Capital Financial Advisors first reported a position in KIDS in Q1 2020 and held it in 10 quarters. The position peaked at $4.57M in Q2 2021. 126 funds tracked by Wall St. Rank hold KIDS as of Q3 2022.

  • United Capital Financial Advisors reported no remaining OrthoPediatrics position as of Q3 2022 after selling out during the quarter.
  • United Capital Financial Advisors sold 59,941 OrthoPediatrics shares in Q3 2022, an estimated $2.59M.
  • United Capital Financial Advisors first reported a position in OrthoPediatrics in Q1 2020 and held it in 10 quarters.
  • United Capital Financial Advisors's OrthoPediatrics position peaked at $4.57M in Q2 2021.
  • 126 funds tracked by Wall St. Rank held OrthoPediatrics as of Q3 2022.

Based on United Capital Financial Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.